IARF Conference Secure Registration
IC-OTR · Registering as Listener

International Conference on Oncology and Translational Research

17–18 Dec 2026 Manchester, UK Standard / Physical Participation
Listener Registration
$140
virtual · $200 in person
Registration Benefits:
Official invitation letterIssued automatically after registration
Certificate & digital materialsGet certificate, slides and resource materials
Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

Coupon code

Have a code? Apply it here — the discount updates the total immediately.

Apply
View full Refund, Cancellation & Terms policy
Conference Programme and Participation Policy

Depending on accepted submissions and scheduling needs, the Organiser may combine compatible research themes across disciplines within an interdisciplinary or multidisciplinary programme that supports knowledge sharing, networking, and professional cooperation.

Refund, Cancellation, Postponement, Travel and Transfer of Registration:
Refund Policy:

If the registrant is unable to attend and is not in a position to transfer his/her participation to another person or event, then the following refund arrangements apply: Keeping given advance payments towards Venue, Printing, Shipping, Hotels, and other overheads, we had to keep the Refund Policy as the following slabs:

1. Cancellations made before 60 days of the conference are eligible for a full refund, subject to a $100 cancellation charge.
2. Cancellations made within 60-30 days of the conference are eligible for a 50% payment refund.
3. Cancellations made within 30 days of the conference are not eligible for a refund.
4. Virtual Participation registrations are non-refundable.

(a) The above refund policies are applicable only if the registrant has not received the official invitation letter for participation in the event, If the client receives the conference invitation letter but cannot attend the conference, no refund will be provided.

(b) If the client cannot attend the conference for any personal reasons, the registration fee is not refundable. However, the fee will be considered as a credit to participate in any of our international conferences within one year from the date of registration.

(c) In the event of a visa denial, travel reasons, or natural calamities preventing attendance, the registration fee will not be refunded. However, the fee will be considered as a credit to participate in any of our international conferences within one year from the date of registration.

(d) Since this conference is hybrid, the organizer reserves the right to conduct it in any format, physical or virtual. Refunds will not be provided for format changes.

(e) For participants who register close to the conference date or after the standard registration deadline, The registration will be considered for virtual participation only, as the conference is in hybrid mode. However, you will be eligible to attend one more international conference based on your registration category.

Cancellation Policy:

If the organizer cancels this event for any reason, you will receive a credit for 100% of the registration fee paid. You may use this credit for another event which must occur within one year from the date of cancellation.

Postponement of Event:

If the organizer postpones an event for any reason and you are unable or unwilling to attend on rescheduled dates, you will receive a credit for 100% of the registration fee paid. You may use this credit for another event which must occur within one year from the date of postponement.

Travel and Accommodation Responsibilities:

a) The responsibility for making and managing travel arrangements, including flights, transportation, and accommodation, lies solely with the individual participant.

b) In the event of any changes to the conference format, cancellation, or venue adjustments, the organizers cannot assume responsibility for any costs incurred by participants for travel or accommodation.

Transfer of registration:

All fully paid registrations are transferable to other persons from the same organization if the registered person is unable to attend the event. Transfers must be made by the registered person in writing to [email protected]. Details must include the full name of the replacement person, their title, contact phone number, and email address. All other registration details will be assigned to the new person unless otherwise specified. Registration can be transferred from one conference to another conference of the same organizer if the registrant is unable to attend one of the conferences

However, Registration cannot be transferred if it is intimated within 14 days of the respective conference. The transferred registrations will not be eligible for Refund.

Visa Information:

The organizer will not directly contact embassies and consulates on behalf of visa applicants. All delegates or invitees should take responsibility for their visa and travel arrangements. Important note for failed visa applications: Visa issues cannot come under the consideration of the cancellation policy of the organizer, including the inability to obtain a visa.

N.B:

All cancellations or modifications of registration must be made in writing to [email protected]

Payments encrypted & processed securely. Refundable up to 14 days before the event.

What you'll hear about

Session tracks covered across the conference.

This track focuses on the latest discoveries in cancer biology, including the molecular mechanisms underlying tumor initiation and progression. Researchers are encouraged to present their findings on cellular signaling pathways and genetic alterations associated with various cancer types.
This session will explore cutting-edge immunotherapeutic strategies for cancer treatment, including checkpoint inhibitors and CAR-T cell therapies. Participants will discuss the mechanisms of action, clinical efficacy, and potential challenges in the application of these therapies.
This track will delve into the role of precision medicine in tailoring cancer treatment to individual patient profiles. Presentations will highlight the integration of genomic data and biomarkers in the development of personalized therapeutic approaches.
This session aims to discuss the identification and validation of biomarkers for cancer diagnosis, prognosis, and treatment response. Researchers are invited to share their insights on the clinical utility of biomarkers in improving patient outcomes.
This track will address the design and implementation of clinical trials in oncology, focusing on innovative trial designs and regulatory considerations. Discussions will include challenges faced in patient recruitment, data management, and regulatory compliance.
This session will investigate the complex interactions within the tumor microenvironment and their impact on cancer metastasis. Researchers are encouraged to present studies on the role of stromal cells, extracellular matrix, and immune cells in tumor progression.
This track will highlight novel therapeutic agents and strategies currently under investigation for cancer treatment. Presentations will cover small molecules, biologics, and combination therapies aimed at enhancing treatment efficacy.
This session will focus on strategies for cancer prevention and the importance of early detection in improving survival rates. Researchers will discuss epidemiological studies, screening methods, and public health initiatives aimed at reducing cancer incidence.
This track will emphasize the translation of laboratory findings into clinical applications in oncology. Presenters will share their experiences in bridging the gap between basic research and clinical practice to enhance patient care.
This session will explore the impact of health disparities on cancer outcomes and access to care. Researchers are invited to present studies addressing socioeconomic, racial, and geographic factors influencing cancer treatment and survival.
This track will provide a platform for discussing future trends and emerging technologies in cancer research. Participants will explore the potential of artificial intelligence, big data, and novel therapeutic approaches in shaping the future of oncology.